Subscribe To
Biocorrx to present at the ld micro invitational xii on june 7th
ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of inn...
May 31, 2022, 9:00 am
Nkarta to participate at upcoming investor conference
SOUTH SAN FRANCISCO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical...
May 31, 2022, 7:02 am
Gsk to pay up to $3.3 billion for biopharma affinivax
GSK PLC said Tuesday that it has agreed to buy clinical-stage biopharmaceutical company Affinivax, Inc....
May 31, 2022, 4:50 am
Britain's gsk to buy affinivax in $3.3 billion deal
British drugmaker GSK said on Tuesday it would pay up to $3.3 billion to acquire privately held biopharmaceuti...
May 31, 2022, 2:16 am
Pharmadrug closes first tranche of a non-brokered private placement for aggregate gross proceeds of $280,000
PharmaDrug Inc has announced the closing of the first tranche of a non-brokered private placement which saw the company issue 7 million units at a pri...
May 30, 2022, 6:05 am
Inovio pharmaceuticals (ino) stock price: why it rose over 14% today
The stock price of INOVIO pharmaceuticals Inc (NASDAQ: INO) increased by over 14% during intraday tradi...
May 27, 2022, 3:04 pm
Vistagen to participate in upcoming june investor conferences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a late clinical-stage, central nervous system (CNS)-focused ...
May 27, 2022, 8:30 am
Two large-cap pharmaceutical stocks with a solid dividend yield
With healthcare costs rising in the U.S., it seems as if the new drugs will have to follow suit. Big....
May 27, 2022, 6:38 am
Zymeworks announces participation in upcoming investor conference
VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharm...
May 27, 2022, 5:30 am
Biomea fusion to present new preclinical data showing bmf-219's strong activity in relapsed/refractory chronic lymphocytic leukemia (cll) tumor models at asco 2022
REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage bio...
May 26, 2022, 6:30 pm
Verrica (vrca) down 64% as molluscum drug gets crl from fda
Verrica pharmaceuticals' (VRCA) new drug application for VP-102 to treat molluscum contagiosum faces re...
May 26, 2022, 5:18 pm
Karyopharm to present new selinexor data at the 2022 american society of clinical oncology annual meeting
– Encouraging Initial Data Observed in Phase 1/2 Study of Selinexor in Combination with Ruxolitinib in Treatment-Naïve Myelofibrosis, Including Fav...
May 26, 2022, 5:08 pm
Elevation oncology to present initial seribantumab proof-of-concept data from phase 2 crestone study in patients with tumors harboring nrg1 fusions at asco 2022
Positive initial data support the potential of seribantumab to induce deep and durable benefit for patients with tumors harboring NRG1 fusions Clinica...
May 26, 2022, 5:05 pm
Spectrum pharmaceuticals to present data at 2022 asco highlighting the potential predictive capabilities of ctdna as a biomarker for poziotinib treatment response
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum pharmaceuticals (NasdaqGS: SPPI), a bio...
May 26, 2022, 5:01 pm
Fda grants priority review to reata's rare disease drug
Shares of Reata pharmaceuticals Inc. RETA, +3.01% were up 2.4% in trading on Thursday after the company...
May 26, 2022, 2:31 pm
Why is nrx pharmaceuticals (nrxp) stock down 60% today?
Today, investors in NRx pharmaceuticals and NRXP stock have seen heavy selling pressure as a key trial ...
May 26, 2022, 2:26 pm
Eagle pharmaceuticals to present at the william blair 42nd annual growth stock conference
WOODCLIFF LAKE, N.J., May 26, 2022 (GLOBE NEWSWIRE) -- Eagle pharmaceuticals, Inc. (Nasdaq: EGRX) (“E...
May 26, 2022, 6:50 am
Diamedica therapeutics to attend the 19th annual craig-hallum institutional investor conference wednesday, june 1, 2022
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...
May 25, 2022, 4:15 pm
Rbc capital slashes verrica's price target after third rejection - what's next?
Verrica pharmaceuticals Inc (NASDAQ: VRCA) was slapped with a third FDA rejection for YCANTH (VP-102...
May 25, 2022, 3:23 pm
Why verrica pharma shares are plunging today
The FDA has issued a Complete Response Letter (CRL) regarding Verrica pharmaceuticals Inc's (NASDAQ...
May 25, 2022, 6:56 am